Lumos Diagnostics Holdings (ASX:LDX) Debt-to-Equity : 0.92 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Debt-to-Equity?

Lumos Diagnostics Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.35 Mil. Lumos Diagnostics Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$11.39 Mil. Lumos Diagnostics Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$13.79 Mil. Lumos Diagnostics Holdings's debt to equity for the quarter that ended in Dec. 2023 was 0.92.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Lumos Diagnostics Holdings's Debt-to-Equity or its related term are showing as below:

ASX:LDX' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.42 Max: 1.03
Current: 0.92

During the past 2 years, the highest Debt-to-Equity Ratio of Lumos Diagnostics Holdings was 1.03. The lowest was 0.06. And the median was 0.42.

ASX:LDX's Debt-to-Equity is ranked worse than
85.05% of 194 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.225 vs ASX:LDX: 0.92

Lumos Diagnostics Holdings Debt-to-Equity Historical Data

The historical data trend for Lumos Diagnostics Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Debt-to-Equity Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Debt-to-Equity

0.40

1.03

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			0.18	0.40	0.44	1.03	0.92

Competitive Comparison of Lumos Diagnostics Holdings's Debt-to-Equity

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Debt-to-Equity falls into.

Lumos Diagnostics Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Lumos Diagnostics Holdings's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.037	+	11.543)	/	14.152
	=	1.03

Lumos Diagnostics Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.354	+	11.386)	/	13.785
	=	0.92

Lumos Diagnostics Holdings (ASX:LDX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Lumos Diagnostics Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines